$175 Million is the total value of Polaris Venture Management Co. V, L.L.C.'s 11 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 10.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ASNS | Arsanis, Inc. | $42,780,000 | +79.4% | 1,868,957 | 0.0% | 24.39% | +16.0% | |
CDLX | New | Cardlytics, Inc. | $38,569,000 | – | 2,636,262 | +100.0% | 21.99% | – |
KALA | Kala Pharmaceuticals, Inc. | $29,406,000 | -14.4% | 1,857,582 | 0.0% | 16.76% | -44.6% | |
FATE | Fate Therapeutics, Inc. | $24,138,000 | +59.7% | 2,473,186 | 0.0% | 13.76% | +3.3% | |
SELB | Selecta Biosciences, Inc. | $16,373,000 | +3.9% | 1,606,813 | 0.0% | 9.33% | -32.8% | |
TTOO | T2 Biosystems, Inc. | $12,172,000 | +57.5% | 1,875,524 | 0.0% | 6.94% | +1.8% | |
LIFE | Atyr Pharma Inc. | $4,844,000 | -24.3% | 1,827,992 | 0.0% | 2.76% | -51.1% | |
TRVN | Trevena, Inc. | $3,368,000 | +2.5% | 2,053,540 | 0.0% | 1.92% | -33.7% | |
GNCA | Genocea Biosciences, Inc. | $2,067,000 | -9.5% | 1,968,606 | 0.0% | 1.18% | -41.5% | |
PULM | Pulmatrix, Inc. | $1,423,000 | -63.9% | 2,796,407 | 0.0% | 0.81% | -76.7% | |
DARE | Dare Bioscience, Inc. | $273,000 | -61.3% | 326,243 | 0.0% | 0.16% | -75.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-05-04
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Fate Therapeutics, Inc. | 30 | Q2 2021 | 79.2% |
Atyr Pharma Inc. | 26 | Q3 2021 | 15.1% |
Trevena, Inc. | 22 | Q2 2019 | 24.9% |
Genocea Biosciences, Inc. | 21 | Q1 2019 | 32.5% |
Selecta Biosciences, Inc. | 20 | Q1 2021 | 39.5% |
T2 Biosystems, Inc. | 20 | Q2 2019 | 36.1% |
Dare Bioscience, Inc. | 17 | Q3 2021 | 3.9% |
Pulmatrix, Inc. | 16 | Q1 2019 | 15.4% |
Cerulean Pharma Inc | 13 | Q2 2017 | 16.2% |
Kala Pharmaceuticals, Inc. | 11 | Q1 2020 | 37.1% |
View Polaris Venture Management Co. V, L.L.C.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
3 | 2022-03-30 |
13F-HR | 2021-11-12 |
13F-HR | 2021-08-12 |
13F-HR | 2021-05-12 |
13F-HR | 2021-02-12 |
13F-HR | 2020-11-12 |
13F-HR | 2020-08-12 |
13F-HR | 2020-05-14 |
4 | 2020-05-06 |
3 | 2020-04-30 |
View Polaris Venture Management Co. V, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.